ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,534,136 | -13.8% | 54,771 | -3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,780,000 | +163.8% | 56,869 | +137.6% | 0.00% | – |
| Q1 2023 | $674,812 | +4.9% | 23,938 | -2.7% | 0.00% | – |
| Q4 2022 | $643,164 | +19.5% | 24,614 | +2.2% | 0.00% | – |
| Q3 2022 | $538,000 | -72.4% | 24,092 | -71.2% | 0.00% | -100.0% |
| Q4 2021 | $1,949,000 | -26.1% | 83,794 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $2,637,000 | +52.7% | 85,492 | +21.4% | 0.00% | 0.0% |
| Q2 2021 | $1,727,000 | +32.4% | 70,437 | +0.9% | 0.00% | – |
| Q1 2021 | $1,304,000 | – | 69,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |